Outcome of First Salvage Therapy in Patients With Chronic Lymphocytic Leukemia Relapsing After First-line Fludarabine, Cyclophosphamide, and Rituximab
Clinical Lymphoma and Myeloma · 2009-12 · 9 (6) · E39-E40
DOI: 10.3816/clm.2009.n.101 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Lymphoma and Myeloma, 2009-12. Verfasst von Xavier Badoux und 4 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Badoux, X., Tam, C., Lerner, S., Wierda, W., & Keating, M. J. (2009). Outcome of First Salvage Therapy in Patients With Chronic Lymphocytic Leukemia Relapsing After First-line Fludarabine, Cyclophosphamide, and Rituximab. Clinical Lymphoma and Myeloma, 9(6), E39-E40. https://doi.org/10.3816/clm.2009.n.101
Vancouver
Badoux X, Tam C, Lerner S, Wierda W, Keating MJ. Outcome of First Salvage Therapy in Patients With Chronic Lymphocytic Leukemia Relapsing After First-line Fludarabine, Cyclophosphamide, and Rituximab. Clinical Lymphoma and Myeloma. 2009;9(6):E39-E40. doi:10.3816/clm.2009.n.101
BibTeX
@article{Badoux2009,
author = {Badoux, Xavier and Tam, Constantine and Lerner, Susan and Wierda, William and Keating, Michael J.},
title = {Outcome of First Salvage Therapy in Patients With Chronic Lymphocytic Leukemia Relapsing After First-line Fludarabine, Cyclophosphamide, and Rituximab},
journal = {Clinical Lymphoma and Myeloma},
year = {2009},
volume = {9},
number = {6},
pages = {E39--E40},
doi = {10.3816/clm.2009.n.101}
}
EUVIMED